Armata Pharmaceuticals (ARMP) Institutional Ownership $1.95 -0.03 (-1.52%) (As of 12/20/2024 04:32 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesOwnershipSEC FilingsShort Interest Institutional Ownership Changes (13F Filings) for Armata Pharmaceuticals (NYSEAMERICAN:ARMP)CurrentInstitutional OwnershipPercentage3.57%Number ofInstitutional Buyers(last 12 months)1Number ofInstitutional Sellers(last 12 months)0 Get ARMP Insider Trade Alerts Want to know when executives and insiders are buying or selling Armata Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ARMP Institutional Buying and Selling by Quarter Ad Brownstone ResearchCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.Click here to see the details because I believe a lot of people will get rich. Armata Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/18/2024 SeaCrest Wealth Management LLC32,777$137K0.0%+80.8%0.091% 11/12/2021 Renaissance Technologies LLC106,092$384K0.0%-9.1%0.425% 11/9/2021BlackRock Inc.20,571$74K0.0%+928.0%0.082% 11/8/2021 Synovus Financial Corp48,060$174K0.0%+108.4%0.193% 8/17/2021 Bridgeway Capital Management LLC113,400$450K0.0%+134.3%0.455% 8/13/2021 Renaissance Technologies LLC116,696$463K0.0%-5.8%0.468% 8/13/2021 Vanguard Group Inc.167,378$665K0.0%+121.4%0.671% 5/21/2021 Citadel Advisors LLC21,306$102K0.0%N/A0.085% 5/18/2021 Millennium Management LLC15,401$74K0.0%N/A0.062% 5/18/2021 Loomis Sayles & Co. L P129,956$621K0.0%N/A0.521% 5/18/2021 Citadel Advisors LLC21,306$102K0.0%N/A0.085% 5/13/2021 Renaissance Technologies LLC123,816$592K0.0%+25.1%0.496% 5/13/2021 Edgewood Management LLC50,000$239K0.0%+25.0%0.200% 5/12/2021 Geode Capital Management LLC10,188$48K0.0%N/A0.041% 5/12/2021 UBS Group AG6,017$29K0.0%+73.4%0.024% 5/7/2021BlackRock Inc.40,448$194K0.0%+12.4%0.162% 2/10/2021 Renaissance Technologies LLC98,996$295K0.0%+5.7%0.529% 2/5/2021BlackRock Inc.35,982$107K0.0%-12.1%0.192% (Data available from 1/1/2016 forward) ARMP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ARMP shares? During the previous two years, the following institutional investors and hedge funds held shares of Armata Pharmaceuticals shares: SeaCrest Wealth Management LLC ($137K).Learn more on ARMP's institutional investors. What percentage of Armata Pharmaceuticals stock is owned by institutional investors? 3.57% of Armata Pharmaceuticals stock is owned by institutional investors. Learn more on ARMP's institutional investor holdings. Which institutional investors have been buying Armata Pharmaceuticals stock? The following institutional investors have purchased Armata Pharmaceuticals stock in the last 24 months: SeaCrest Wealth Management LLC ($14.65K). How much institutional buying is happening at Armata Pharmaceuticals? Institutional investors have bought a total of 14,647 shares in the last 24 months. This purchase volume represents approximately $0.00 in transactions. Related Companies AC Immune Institutional Ownership Amylyx Pharmaceuticals Institutional Ownership Lifecore Biomedical Institutional Ownership iTeos Therapeutics Institutional Ownership Eledon Pharmaceuticals Institutional Ownership UroGen Pharma Institutional Ownership Atea Pharmaceuticals Institutional Ownership Chimerix Institutional Ownership Rezolute Institutional Ownership Mersana Therapeutics Institutional Ownership This page (NYSEAMERICAN:ARMP) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Armata Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Armata Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
